Separate website addresses are provided for each of the following functions: home page, enrollment, queries, and data upload. Contact information is provided for the NJPMP Program Administrator. Data for 2017 cover the state population (9,032,872), DEA registered prescribers (48,944), and DEA registered dispensers (2,110). NJPMP available reports are listed. Funding sources for 2018 were controlled substance registration fees and a Harold Rogers grant. Personnel numbers for 2018 are reported for the following job categories: operational (2), technical (1), analytical (1), and "other" (0). Key dates for the NJPMP pertain to enabling legislation (January 2008), becoming operational (September 2011), initial user access (January 2012), on-line access (January 2012), and electronic reporting (September 2011). Source information is provided for statutes and rules relevant to NJPMP policies and procedures. The frequency of reporting on monitored drugs is daily. Monitored drugs are the controlled substances in schedules II, III, IV, and V. The NJPMP also requires reporting on the administering of naloxone, opioid-related drug overdoses or deaths, registrant's disciplinary history/status, and lost/stolen prescription drugs. The NJPMP has the authority to monitor other substances and remove substances from monitoring. Miscellaneous capabilities and policies are listed. Enrollment in and use of the NJPMP is required for both prescribers and dispensers of monitored drugs. Queries by law enforcement personnel require a subpoena and court order/approval and must be submitted on-line or by written request. Training in the use of the NJPMP is required and available for prescribers. dispensers, law enforcement personnel, and researchers. Other information addresses technological capabilities and reports produced by requestor type.
Prescription Drug Monitoring Program: New Jersey State Profile
NCJ Number
253019
Date Published
October 2018
Length
8 pages
Annotation
Information and data are presented for the New Jersey Prescription Drug Monitoring Program (PDMP), named the New Jersey Prescription Monitoring Program (NJPMP). which is administered by the state law enforcement agency.
Abstract